Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 11(1): 910, 2021 01 13.
Article in English | MEDLINE | ID: mdl-33441611

ABSTRACT

Post-menopausal depression (PMD) is a common psychological disorder accompanied by a cognitive deficit, which is caused by a series of uncontrolled emotional disruptions by strong environmental stressors during menopause. To overcome PMD-induced cognitive deficit, Green tea has been suggested as a dietary supplement because of its ameliorating effect on cognitive dysfunction induced by normal aging or neurodegenerative syndromes; however, its clinical use to improve PMD-accompanied cognitive deficit is still limited due to the controversy for the active ingredients and ambiguous mechanism of its action. Here, we developed modified high-temperature-processed green tea extract (HTP-GTE), which showed lower neuronal toxicity than the conventional green tea extract (GTE). We also demonstrated that HTP-GTE administration prevented the development of learned helplessness (LH) in a rat post-menopausal model. Additionally, HTP-GTE improved LH-induced cognitive impairments simultaneously with rescued the long-term synaptic plasticity. This occurred via the restoration of silent synapse formation by increasing the hippocampal BDNF-tyrosine receptor kinase B pathway in the helpless ovariectomized (OVX) rats. Likewise, we also identified that (-)-gallocatechin gallate was the main contributor of the HTP-GTE effect. Our findings suggested that HTP-GTE has a potential as a preventive nutritional supplement to ameliorate cognitive dysfunctions associated with PMD.


Subject(s)
Catechin/analogs & derivatives , Cognitive Dysfunction/diet therapy , Postmenopause/psychology , Animals , Antioxidants/pharmacology , Catechin/metabolism , Catechin/pharmacology , Cognition Disorders/diet therapy , Depression/diet therapy , Depression/metabolism , Dietary Supplements , Female , Hippocampus/drug effects , Hippocampus/metabolism , Plant Extracts/pharmacology , Rats , Rats, Sprague-Dawley , Synapses/drug effects , Tea/metabolism
2.
Toxins (Basel) ; 11(7)2019 07 08.
Article in English | MEDLINE | ID: mdl-31288453

ABSTRACT

Oxaliplatin is a chemotherapeutic agent used for metastatic colon and other advanced cancers. Most common side effect of oxaliplatin is peripheral neuropathy, manifested in mechanical and cold allodynia. Although the analgesic effect of bee venom has been proven to be effective against oxaliplatin-induced peripheral neuropathy, the effect of its major component; melittin has not been studied yet. Thus, in this study, we investigated whether melittin has an analgesic effect on oxaliplatin-induced allodynia. Intraperitoneal single injection of oxaliplatin (6 mg/kg) induced mechanical and cold allodynia, resulting in increased withdrawal behavior in response to von Frey filaments and acetone drop on hind paw. Subcutaneous melittin injection on acupoint ST36 (0.5 mg/kg) alleviated oxaliplatin-induced mechanical and cold allodynia. In electrophysiological study, using spinal in vivo extracellular recording, it was shown that oxaliplatin-induced hyperexcitation of spinal wide dynamic range neurons in response to peripheral stimuli, and melittin administration inhibited this neuronal activity. In behavioral assessment, analgesic effect of melittin was blocked by intrathecal α1- and α2- adrenergic receptor antagonists administration. Based on these results, we suggest that melittin could be used as an analgesic on oxaliplatin-induced peripheral neuropathy, and that its effect is mediated by activating the spinal α1- and α2-adrenergic receptors.


Subject(s)
Analgesics/therapeutic use , Hyperalgesia/drug therapy , Melitten/therapeutic use , Peripheral Nervous System Diseases/drug therapy , Adrenergic alpha-1 Receptor Antagonists/pharmacology , Adrenergic alpha-2 Receptor Antagonists/pharmacology , Analgesics/pharmacology , Animals , Antineoplastic Agents , Cold Temperature , Hyperalgesia/chemically induced , Idazoxan/pharmacology , Melitten/pharmacology , Neurons/drug effects , Neurons/physiology , Oxaliplatin , Peripheral Nervous System Diseases/chemically induced , Prazosin/pharmacology , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha-1/physiology , Receptors, Adrenergic, alpha-2/physiology , Spinal Cord/drug effects , Spinal Cord/physiology , Touch
3.
Nutrients ; 11(2)2019 Feb 19.
Article in English | MEDLINE | ID: mdl-30791474

ABSTRACT

A chemotherapy drug, oxaliplatin, induces cold and mechanical hypersensitivity, but effective treatments for this neuropathic pain without side effects are still lacking. We previously showed that Cinnamomi Cortex suppresses oxaliplatin-induced pain behaviors in rats. However, it remains unknown which phytochemical of Cinnamomi Cortex plays a key role in that analgesic action. Thus, here we investigated whether and how cinnamic acid or cinnamaldehyde, major components of Cinnamomi Cortex, alleviates cold and mechanical allodynia induced by a single oxaliplatin injection (6 mg/kg, i.p.) in rats. Using an acetone test and the von Frey test for measuring cold and mechanical allodynia, respectively, we found that administration of cinnamic acid, but not cinnamaldehyde, at doses of 10, 20 and 40 mg/kg (i.p.) significantly attenuates the allodynic behaviors in oxaliplatin-injected rats with the strongest effect being observed at 20 mg/kg. Our in vivo extracellular recordings also showed that cinnamic acid (20 mg/kg, i.p.) inhibits the increased activities of spinal wide dynamic range neurons in response to cutaneous mechanical and cold stimuli following the oxaliplatin injection. These results indicate that cinnamic acid has an effective analgesic action against oxaliplatin-induced neuropathic pain through inhibiting spinal pain transmission, suggesting its crucial role in mediating the effect of Cinnamomi Cortex.


Subject(s)
Acrolein/analogs & derivatives , Cinnamates/therapeutic use , Cinnamomum aromaticum/chemistry , Drugs, Chinese Herbal/therapeutic use , Neuralgia/prevention & control , Oxaliplatin/adverse effects , Spinal Cord/drug effects , Acrolein/pharmacology , Analgesics/pharmacology , Analgesics/therapeutic use , Animals , Antineoplastic Agents/adverse effects , Cinnamates/pharmacology , Cinnamomum zeylanicum , Cold Temperature , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Hyperalgesia/chemically induced , Hyperalgesia/prevention & control , Male , Neuralgia/chemically induced , Organoplatinum Compounds/adverse effects , Rats, Sprague-Dawley
4.
Bioorg Med Chem Lett ; 27(11): 2415-2419, 2017 06 01.
Article in English | MEDLINE | ID: mdl-28416130

ABSTRACT

In this study, we synthesized an Azo-py phosphoramidite, featuring azobenzene and pyrene units, as a novel fluorescent and isomeric (trans- and cis-azobenzene units) material, which we incorporated in an i-motif DNA sequence. We then monitored the structural dynamics and changes in fluorescence as the modified DNA sequences transformed from single strands at pH 7 to i-motif quadruplex structures at pH 3. After incorporating Azo-py into the 4A loop position of an i-motif sequence, dramatic changes in fluorescence occurred as the DNA structures changed from single-strands to i-motif quadruplex structures. Interestingly, the cis form of Azo-py induced a more stable i-motif structure than did the trans form, as confirmed from circular dichroism spectra and melting temperature data. The absorption and fluorescence signals of these Azo-py-incorporated i-motif systems exhibited switchable and highly correlated signaling patterns. Such isomeric structures based on Azo-py might find potential applications in biology, where control over stable i-motif quadruplex structures might be performed with switchable fluorescence signaling.


Subject(s)
Azo Compounds/chemistry , DNA, Single-Stranded/chemistry , Fluorescent Dyes/chemistry , Pyrenes/chemistry , Azo Compounds/chemical synthesis , Circular Dichroism , Fluorescence , Fluorescent Dyes/chemical synthesis , Hydrogen-Ion Concentration , Organophosphorus Compounds/chemical synthesis , Organophosphorus Compounds/chemistry , Pyrenes/chemical synthesis , Spectrophotometry, Ultraviolet , Stereoisomerism , Transition Temperature
SELECTION OF CITATIONS
SEARCH DETAIL